Literature DB >> 14752064

Inhibition of nitric oxide generation by 23,24-dihydrocucurbitacin D in mouse peritoneal macrophages.

Chang Seok Park1, Hyun Lim, Kee Jung Han, Sun Heum Baek, Hyung Ok Sohn, Dong Wook Lee, Yang-Gyun Kim, Hye-Young Yun, Kwang Jin Baek, Nyoun Soo Kwon.   

Abstract

Nitric oxide (NO) has various physiological functions. However, uncontrolled overproduction of NO can be toxic in many pathologic conditions involving inflammatory tissue damage. In the present study, we examined effects of 23,24-dihydrocucurbitacin D (DHCD) isolated from the root of Bryonia alba L. on macrophage NO generation. DHCD (<80 microM) effectively abolished NO generation from macrophages activated with lipopolysaccharide and interferon-gamma. DHCD decreased the levels of protein and mRNA for inducible NO synthase (iNOS). DHCD potently blocked nuclear factor-kappaB (NF-kappaB) activation, a process necessary for transcriptional activation of iNOS. These results suggested that DHCD inhibited NO generation by blocking NF-kappaB activation and iNOS gene transcription. Because NF-kappaB activation is necessary not only for NO generation but also for many inflammatory processes, DHCD and its derivatives could be developed as anti-inflammatory drugs.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14752064     DOI: 10.1124/jpet.103.063693

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  8 in total

1.  Inhibition of nuclear transcription factor-κB and activation of peroxisome proliferator-activated receptors in HepG2 cells by cucurbitane-type triterpene glycosides from Momordica charantia.

Authors:  Nguyen Xuan Nhiem; Pham Hai Yen; Nguyen Thi Thanh Ngan; Tran Hong Quang; Phan Van Kiem; Chau Van Minh; Bui Huu Tai; Nguyen Xuan Cuong; Seok Bean Song; Young Ho Kim
Journal:  J Med Food       Date:  2012-01-16       Impact factor: 2.786

2.  Cucurbitacin D induces growth inhibition, cell cycle arrest, and apoptosis in human endometrial and ovarian cancer cells.

Authors:  Terukazu Ishii; Naoko Kira; Toshie Yoshida; Hisashi Narahara
Journal:  Tumour Biol       Date:  2012-11-14

3.  Cucurbitacins - a promising target for cancer therapy.

Authors:  Abdullah A Alghasham
Journal:  Int J Health Sci (Qassim)       Date:  2013-01

4.  Cucurbitacin I inhibits cell motility by indirectly interfering with actin dynamics.

Authors:  David A Knecht; Rebecca A LaFleur; Alem W Kahsai; Christian E Argueta; Anwar B Beshir; Gabriel Fenteany
Journal:  PLoS One       Date:  2010-11-24       Impact factor: 3.240

5.  Cucurbitacin L 2-O-β-Glucoside Demonstrates Apoptogenesis in Colon Adenocarcinoma Cells (HT-29): Involvement of Reactive Oxygen and Nitrogen Species Regulation.

Authors:  Siddig Ibrahim Abdelwahab; Loiy Elsir Ahmed Hassan; Amin M S Abdul Majid; Sakina M Ahmed Yagi; Syam Mohan; Manal Mohamed Elhassan Taha; Syahida Ahmad; Cheah Shiau Chuen; Putri Narrima; Mohd Mustafa Rais; Suvitha Syam; Bushra Abdulkarim Moharam; A Hamid A Hadi
Journal:  Evid Based Complement Alternat Med       Date:  2012-02-26       Impact factor: 2.629

Review 6.  Cucurbitacins - An insight into medicinal leads from nature.

Authors:  Ujjwal Kaushik; Vidhu Aeri; Showkat R Mir
Journal:  Pharmacogn Rev       Date:  2015 Jan-Jun

Review 7.  An Evidence-Based Study on Medicinal Plants for Hemorrhoids in Medieval Persia.

Authors:  Mohammad Hashem Hashempur; Fatemeh Khademi; Maryam Rahmanifard; Mohammad M Zarshenas
Journal:  J Evid Based Complementary Altern Med       Date:  2017-01-24

8.  Cucurbitacin E Inhibits Huh7 Hepatoma Carcinoma Cell Proliferation and Metastasis via Suppressing MAPKs and JAK/STAT3 Pathways.

Authors:  Yang Liu; Heng Yang; Qiang Guo; Tingting Liu; Yong Jiang; Mingbo Zhao; Kewu Zeng; Pengfei Tu
Journal:  Molecules       Date:  2020-01-28       Impact factor: 4.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.